Suppr超能文献

迈向消灭脊髓灰质炎的进展 - 巴基斯坦,2021 年 1 月至 2022 年 7 月。

Progress Toward Poliomyelitis Eradication - Pakistan, January 2021-July 2022.

出版信息

MMWR Morb Mortal Wkly Rep. 2022 Oct 21;71(42):1313-1318. doi: 10.15585/mmwr.mm7142a1.

Abstract

After reporting a single wild poliovirus (WPV) type 1 (WPV1) case in 2021, Pakistan reported 14 cases during April 1-July 31, 2022. Pakistan and Afghanistan are the only countries where endemic WPV transmission has never been interrupted (1). In its current 5-year strategic plan, the Global Polio Eradication Initiative (GPEI) has set a goal of interrupting all WPV1 transmission by the end of 2023 (1-3). The reemergence of WPV cases in Pakistan after 14 months with no case detection has uncovered transmission in southern Khyber Pakhtunkhwa province, the most historically challenging area. This report describes Pakistan's progress toward polio eradication during January 2021-July 2022 and updates previous reports (4,5). As of August 20, 2022, all but one of the 14 WPV1 cases in Pakistan during 2022 have been reported from North Waziristan district in Khyber Pakhtunkhwa. In underimmunized populations, excretion of vaccine virus can, during a period of 12-18 months, lead to reversion to neurovirulence, resulting in circulating vaccine-derived polioviruses (cVDPVs), which can cause paralysis and outbreaks. An outbreak of cVDPV type 2 (cVDPV2), which began in Pakistan in 2019, has been successfully contained; the last case occurred in April 2021 (1,6). Despite program improvements, 400,000-500,000 children continue to be missed during nationwide polio supplementary immunization activities (SIAs),* and recent isolation of poliovirus from sewage samples collected in other provinces suggests wider WPV1 circulation during the ongoing high transmission season. Although vaccination efforts have been recently complicated by months of flooding during the summer of 2022, to successfully interrupt WPV1 transmission in the core reservoirs in southern Khyber Pakhtunkhwa and reach the GPEI goal, emphasis should be placed on further improving microplanning and supervision of SIAs and on systematic tracking and vaccination of persistently missed children in these reservoir areas of Pakistan.

摘要

2021 年报告了 1 例野生脊髓灰质炎 1 型(WPV1)病例后,巴基斯坦于 2022 年 4 月 1 日至 7 月 31 日期间报告了 14 例病例。巴基斯坦和阿富汗是唯一从未中断过地方性 WPV 传播的国家(1)。在其当前的 5 年战略计划中,全球根除脊髓灰质炎行动(GPEI)设定了到 2023 年底中断所有 WPV1 传播的目标(1-3)。在没有病例检出的情况下,巴基斯坦时隔 14 个月再次出现 WPV 病例,暴露出在历史上最具挑战性的地区——开伯尔-普赫图赫瓦省南部存在传播。本报告介绍了 2021 年 1 月至 2022 年 7 月期间巴基斯坦在消灭脊灰炎方面的进展,并更新了以往的报告(4,5)。截至 2022 年 8 月 20 日,巴基斯坦 2022 年报告的 14 例 WPV1 病例中,除 1 例外,其余均来自开伯尔-普赫图赫瓦省的北瓦济里斯坦地区。在免疫不足的人群中,疫苗病毒的排泄可能在 12-18 个月期间导致返回到神经毒力,从而导致循环疫苗衍生脊髓灰质炎病毒(cVDPV)的出现,这可能导致瘫痪和暴发。2019 年在巴基斯坦开始的 cVDPV2 暴发已成功得到遏制;最后一例发生在 2021 年 4 月(1,6)。尽管方案有所改进,但在全国脊髓灰质炎补充免疫活动(SIA)中仍有 40 万至 50 万儿童被遗漏,*最近在其他省份收集的污水样本中分离出脊灰病毒表明,在当前的高传播季节,WPV1 传播范围更广。尽管最近由于 2022 年夏季的数月洪水使疫苗接种工作变得复杂,但要成功阻断南开伯尔-普赫图赫瓦核心储存库中的 WPV1 传播并实现 GPEI 目标,应重点进一步改进 SIA 的微观规划和监督,并对这些巴基斯坦储存库地区持续漏种的儿童进行系统跟踪和接种。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516c/9590290/729987c0a85c/mm7142a1-F1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验